Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Adamis Pharmaceuticals Corp


Ticker Delisted

As of 13:28:09 ET on 05/05/2015.

Snapshot for Adamis Pharmaceuticals Corp (CY3A)

Open: 3.912 Day's Range: 3.818 - 4.002 Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for CY3A

No chart data available.
  • CY3A:GR 4.002
  • 1D
  • 1M
  • 1Y
Interactive CY3A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CY3A

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (03/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CY3A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CY3A

Adamis Pharmaceuticals Corporation is a bio-pharmaceuticals company. The Company develops and distributes specialty pharmaceutical products in the therapeutic areas of oncology, immunology, infectious diseases, allergy and respiratory. Adamis Pharmaceuticals offers its products to the healthcare industry.

Dennis J CarloPresident/CEODavid J MarguglioSenior VP:Corporate Development
Robert O HopkinsVP:Finance/CFOKaren K DanielsVP:Operations
More Company Profile & Key Executives for CY3A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil